Nicolas Scheuer

417 total citations
12 papers, 304 citations indexed

About

Nicolas Scheuer is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Nicolas Scheuer has authored 12 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Epidemiology. Recurrent topics in Nicolas Scheuer's work include Lung Cancer Treatments and Mutations (4 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and HER2/EGFR in Cancer Research (2 papers). Nicolas Scheuer is often cited by papers focused on Lung Cancer Treatments and Mutations (4 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and HER2/EGFR in Cancer Research (2 papers). Nicolas Scheuer collaborates with scholars based in Switzerland, United States and United Kingdom. Nicolas Scheuer's co-authors include Kate Dolan, Paul Haber, Andrew R. Lloyd, William D. Rawlinson, Suzy Teutsch, Michael Levy, John Kaldor, Vivek Subbiah, Sreeram V Ramagopalan and Stephen V. Liu and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and BMC Public Health.

In The Last Decade

Nicolas Scheuer

12 papers receiving 294 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicolas Scheuer Switzerland 8 137 101 56 49 49 12 304
Vinícius Lins Ferreira Brazil 14 151 1.1× 102 1.0× 31 0.6× 14 0.3× 22 0.4× 34 368
Annie Hung United States 8 49 0.4× 35 0.3× 29 0.5× 32 0.7× 124 2.5× 32 335
Tae Hyup Kim South Korea 8 86 0.6× 61 0.6× 15 0.3× 80 1.6× 57 1.2× 12 356
Baris Deniz United States 10 245 1.8× 249 2.5× 25 0.4× 23 0.5× 47 1.0× 25 412
Ruoyan Gai Tobe China 10 147 1.1× 83 0.8× 17 0.3× 18 0.4× 22 0.4× 22 348
Tianhua He China 11 262 1.9× 275 2.7× 38 0.7× 5 0.1× 15 0.3× 21 562
Silvia Taranto United States 12 75 0.5× 34 0.3× 179 3.2× 107 2.2× 72 1.5× 25 438
Róisín Adams Ireland 12 61 0.4× 27 0.3× 12 0.2× 16 0.3× 21 0.4× 28 387
Ming-Wen An United States 11 40 0.3× 15 0.1× 33 0.6× 82 1.7× 90 1.8× 18 443
Madhulika Mistry India 5 76 0.6× 19 0.2× 60 1.1× 55 1.1× 124 2.5× 15 305

Countries citing papers authored by Nicolas Scheuer

Since Specialization
Citations

This map shows the geographic impact of Nicolas Scheuer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Scheuer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Scheuer more than expected).

Fields of papers citing papers by Nicolas Scheuer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Scheuer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Scheuer. The network helps show where Nicolas Scheuer may publish in the future.

Co-authorship network of co-authors of Nicolas Scheuer

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Scheuer. A scholar is included among the top collaborators of Nicolas Scheuer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Scheuer. Nicolas Scheuer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Gupta, Alind, Grace Hsu, Stephen Duffield, et al.. (2025). Quantitative Bias Analysis for Single-Arm Trials With External Control Arms. JAMA Network Open. 8(3). e252152–e252152. 2 indexed citations
2.
Mott, David, Hareth Al‐Janabi, Becky Pennington, et al.. (2023). Modelling Spillover Effects on Informal Carers: The Carer QALY Trap. PharmacoEconomics. 41(12). 1557–1561. 7 indexed citations
3.
Popat, Sanjay, Stephen V. Liu, Nicolas Scheuer, et al.. (2022). Addressing challenges with real-world synthetic control arms to demonstrate the comparative effectiveness of Pralsetinib in non-small cell lung cancer. Nature Communications. 13(1). 3500–3500. 48 indexed citations
4.
Popat, Sanjay, Stephen V. Liu, Nicolas Scheuer, et al.. (2022). Association Between Smoking History and Overall Survival in Patients Receiving Pembrolizumab for First-Line Treatment of Advanced Non–Small Cell Lung Cancer. JAMA Network Open. 5(5). e2214046–e2214046. 26 indexed citations
5.
Wilkinson, Samantha, Alind Gupta, Nicolas Scheuer, et al.. (2021). Assessment of Alectinib vs Ceritinib in ALK-Positive Non–Small Cell Lung Cancer in Phase 2 Trials and in Real-world Data. JAMA Network Open. 4(10). e2126306–e2126306. 16 indexed citations
6.
7.
Roychoudhury, Satrajit, Nicolas Scheuer, & Beat Neuenschwander. (2018). Beyondp-values: A phase II dual-criterion design with statistical significance and clinical relevance. Clinical Trials. 15(5). 452–461. 17 indexed citations
8.
Ottmann, Oliver G., A Charbonnier, Frank Stegelmann, et al.. (2015). Smoothened (Smo) Inhibitor Lde225 Combined With Nilotinib In Patients With Chronic Myeloid Leukemia (Cml) Resistant/Intolerant (R/I) To At Least 1 Prior Tyrosine Kinase Inhibitor: A Phase 1B Study. ORCA Online Research @Cardiff (Cardiff University). 4 indexed citations
9.
Dolan, Kate, Suzy Teutsch, Nicolas Scheuer, et al.. (2010). Incidence and risk for acute hepatitis C infection during imprisonment in Australia. European Journal of Epidemiology. 25(2). 143–148. 72 indexed citations
10.
11.
Teutsch, Suzy, Fabio Luciani, Nicolas Scheuer, et al.. (2010). Incidence of primary hepatitis C infection and risk factors for transmission in an Australian prisoner cohort. BMC Public Health. 10(1). 70 indexed citations
12.
Degenhardt, Louisa, Briony Larance, James Bell, et al.. (2009). Injection of medications used in opioid substitution treatment in Australia after the introduction of a mixed partial agonist–antagonist formulation. The Medical Journal of Australia. 191(3). 161–165. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vinícius Lins Ferreira Breakdown of academic impact, for papers by Annie Hung Breakdown of academic impact, for papers by Tae Hyup Kim Breakdown of academic impact, for papers by Baris Deniz Breakdown of academic impact, for papers by Ruoyan Gai Tobe Breakdown of academic impact, for papers by Tianhua He Breakdown of academic impact, for papers by Silvia Taranto Breakdown of academic impact, for papers by Róisín Adams Breakdown of academic impact, for papers by Ming-Wen An Breakdown of academic impact, for papers by Madhulika Mistry
Rankless by CCL
2026